ISSN : 2488-8648
International Journal of Basic Science and Technology
A publication of the Faculty of Science, Federal University Otuoke, Bayelsa State
Home About IJBST For Authors Issues Useful Downloads Contact
ISSN : 2488-8648
Home About IJBST For Authors Issues Useful Downloads Contact
Questions are asked and these questions need answers. This is the reason why this page is created to enable us share few worries!
×published date:2016-Dec-14
FULL TEXT in - 
| page 20 -25
Abstract
Prostate cancer (PCa) is the most common male-specific cancer worldwide. More often, PCa is diagnosed early. With the slow development of some PCa cases, there is a wide window of opportunity for chemoprevention. Chemoprevention is intended to improve the quality of life, reduce morbidity and mortality in patients. Based on epidemiological studies, it is believed that dietary agents that are utilised specifically in a part of the world may be related to its low disease incidence profile. Healthier diets in Asia contain high levels of curcumin, diindolylmethane (DIM) and epigallocathechin-gallate (EGCG). These diet-derived agents may be responsible for the much lower cancer incidences in Asia. Our aim is to utilise cell models of PCa (LNCaP cell lines) and investigate the effect of curcumin, DIM, EGCG and their paired combinations on cellular growth and survival through the cell proliferation analysis, ATP and Clonogenic assays. Results from cell proliferation analysis showed significant time-dependent growth inhibition following treatment with curcumin, DIM, EGCG and their paired combinations respectively (P < 0.0001). However the paired combination of these diet-derived agents: curcumin and DIM (C+D), curcumin and EGCG (C+E) and, DIM and EGCG (D+E) did indicate enhanced inhibition to LNCaP cells viability and growth. Further studies need to be conducted for paired combinations of notable diet-derived agents as they may possess improved chemoprevention abilities in dealing with the progression of PCa.
Keywords: curcumin, DIM, EGCG, LNCaP chemoprevention,
Aggarwal, B. B., Kumar, A., & Bharti, A. C. (2003). Anticancer
potential of curcumin: Preclinical and clinical studies. Anticancer
Research, 23(1A), 363-398.
Bertram, J. S., Kolonel, L. N., & Meyskens, F. L. Jr. (1987).
Rationale and strategies for chemoprevention of cancer in
humans. Cancer Research, 47(11), 3012-3031.
Chen, D., & Dou, Q. P. (2008). Tea polyphenols and their roles in
cancer prevention and chemotherapy. International Journal of
Molecular Sciences, 9(7), 1196-1206.
Garikapaty, V. P., Ashok, B. T., Tadi, K., Mittelman, A., &
Tiwari, R. K. (2006). Synthetic dimer of indole-3-carbinol:
Second generation diet derived anti-cancer agent in hormone
sensitive prostate cancer. The Prostate, 66(5), 453-462.
Howells, L. M., Gallacher-Horley, B., Houghton, C. E., Manson,
M. M., & Hudson, E. A. (2002). Indole-3-carbinol inhibits protein
kinase B/Akt and induces apoptosis in the human breast tumor cell
line MDA MB468 but not in the nontumorigenic HBL100
line. Molecular Cancer Therapeutics, 1(13), 1161-1172.
Howells, L. M., & Manson, M. M. (2005). Prospects for plantderived
chemopreventive agents exhibiting multiple mechanisms
of action. Current Medicinal Chemistry. Anti-Cancer
Agents, 5(3), 201-213.
Howells, L. M., Moiseeva, E. P., Neal, C. P., Foreman, B. E.,
Andreadi, C. K., Sun, Y. Y., Manson, M. M. (2007). Predicting
the physiological relevance of in vitro cancer preventive activities
of phytochemicals. Acta Pharmacologica Sinica, 28(9), 1274-
1304.
Howells, L. M., Sale, S., Sriramareddy, S. N., Irving, G. R., Jones,
D. J., Ottley, C. J., Brown, K. (2011). Curcumin ameliorates
oxaliplatin-induced chemoresistance in HCT116 colorectal cancer
cells in vitro and in vivo. International Journal of Cancer, 129(2),
476-486.
Johnson, J. J., Syed, D.N., Heren, C. R., Suh, Y., Adhami, V. M.,
& Mukhtar, H. (2008). Carnosol, a dietary diterpene, displays
growth inhibitory effects in human prostate cancer PC3 cells
leading to G2-phase cell cycle arrest and targets the 5'-AMPactivated
protein kinase (AMPK) pathway. Pharmaceutical
Research, 25(9), 2125-2134.
Khan, N., & Mukhtar, H. (2008). Multitargeted therapy of cancer
by green tea polyphenols. Cancer Letters, 269(2), 269-280.
Kimura, K., Itakura, Y., Goto, R., Tojima, M., Egawa, N., &
Yoshihama, M. (2007). Inhibition of 17alpha-hydroxylase/C17,
20-lyase (CYP17) from rat testis by green tea catechins and black Biochemistry, 71(9), 2325-2328.
Lieberman, R., Bermejo, C., Akaza, H., Greenwald, P., Fair, W.,
& Thompson, I. (2001). Progress in prostate cancer
chemoprevention: Modulators of promotion and
progression. Urology, 58(6), 835-842.
Lin, L., Shi, Q., Nyarko, A. K., Bastow, K. F., Wu, C. C., Su, C.
Y., . . . Lee, K. H. (2006). Antitumor agents. 250. design and
synthesis of new curcumin analogues as potential anti-prostate
cancer agents. Journal of Medicinal Chemistry, 49(13), 3963-
3972.
Lippman, S. M., & Lee, J. J. (2006). Reducing the "risk" of
chemoprevention: Defining and targeting high risk--2005 AACR
cancer research and prevention foundation award lecture. Cancer
Research, 66(6), 2893-2903.
Manson, M. M., Foreman, B. E., Howells, L. M., & Moiseeva, E.
P. (2007). Determining the efficacy of dietary phytochemicals in
cancer prevention. Biochemical Society Transactions, 35(Pt 5),
1358-1363.
Maru, G. B., Hudlikar, R. R., Kumar, G., Gandhi, K., &
Mahimkar, M. B. (2016). Understanding the molecular
mechanisms of cancer prevention by dietary phytochemicals:
From experimental models to clinical trials. World Journal of
Biological Chemistry, 7(1), 88-99.
Montopoli, M., Ragazzi, E., Froldi, G., & Caparrotta, L. (2009).
Cell-cycle inhibition and apoptosis induced by curcumin and
cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell
Proliferation, 42(2), 195-206.
Nachshon-Kedmi, M., Yannai, S., Haj, A., & Fares, F. A. (2003).
Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in
human prostate cancer cells. Food and Chemical Toxicology: AnPaschka, A. G., Butler, R., & Young, C. Y. (1998). Induction of
apoptosis in prostate cancer cell lines by the green tea component,
(-)-epigallocatechin-3-gallate. Cancer Letters, 130(1-2), 1-7.
Pulido-Moran, M., Moreno-Fernandez, J., Ramirez-Tortosa, C., &
Ramirez-Tortosa, M. (2016). Curcumin and health. Molecules
(Basel, Switzerland), 21(3), E264.
Sarkar, F. H., & Li, Y. (2004). Cell signaling pathways altered by
natural chemopreventive agents. Mutation Research, 555(1-2),
53-64.
Shenouda, N. S., Zhou, C., Browning, J. D., Ansell, P. J., Sakla,
M. S., Lubahn, D. B., & Macdonald, R. S. (2004). Phytoestrogens
in common herbs regulate prostate cancer cell growth in
vitro. Nutrition and Cancer, 49(2), 200-208.
Singh, R. P., & Agarwal, R. (2006). Mechanisms of action of
novel agents for prostate cancer chemoprevention. Endocrine-
Related Cancer, 13(3), 751-778.
Thangapazham, R. L., Sharma, A., & Maheshwari, R. K. (2006).
Multiple molecular targets in cancer chemoprevention by
curcumin. The AAPS Journal, 8(3), E443-9.
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J.,
& Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer
Journal for Clinicians, 65(2), 87-108.
Valentini, A., Conforti, F., Crispini, A., De Martino, A., Condello,
R., Stellitano, C., Pucci, D. (2009). Synthesis, oxidant properties,
and antitumoral effects of a heteroleptic palladium (II) complex of
curcumin on human prostate cancer cells. Journal of Medicinal
Chemistry, 52(2), 484-491.
FULL TEXT in - | page 20 -25
Issue 2-Apr-Jun
Issue 1-Jan-Mar
Issue 4-Oct-Dec
Issue 3-Jul-Sep
Issue 2-Apr-Jun
Issue 1-Jan-Mar
Issue 4-Oct-Dec
Issue 3-Jul-Sep
Issue 2-Apr-Jun
Issue 1-Jan-Mar
Issue 4-Oct-Dec
Issue 2-Apr-Jun
Issue 1-Jan-Mar
Issue 4-Oct-Dec
Issue 3-Jul-Sep
Issue 4-Oct-Dec
Issue 2-Apr-Jun
Issue 1-Jan-Mar
Issue 4-Oct-Dec
Issue 3-Jul-Sep
Issue 2-Apr-Jun
Issue 4-Oct-Dec
Issue 1-Jan-Mar
Copyright © International Journal of Basic Science and Technology | Faculty of Science, Federal University Otuoke 2019. All Rights Reserved.
P.M.B. 126, Yenagoa. Bayelsa state Nigeria
Get the most recent updates
and be updated your self...